Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
about
Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation.Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth.H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.Epigenetic Regulation of Apoptosis and Cell Cycle Regulatory Genes in Human Colon Carcinoma Cells.Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.Butyrate histone deacetylase inhibitors.Epigenetics and colorectal cancer pathogenesisSynergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancerEpigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.Epigenetics of colorectal cancer.Promoter CpG island methylation markers in colorectal cancer: the road ahead.Epigenetic biomarkers in colorectal cancer diagnostics.miRNAs as mediators of drug resistance.Genomics and epigenomics of colorectal cancer.Epigenetic therapy for solid tumors: from bench science to clinical trials.Histone Modifications and Cancer.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells.Shape in migration: quantitative image analysis of migrating chemoresistant HCT-8 colon cancer cells.Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.Lysosome-associated protein transmembrane4β is involved in multidrug resistance processes of colorectal cancer.Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis.Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression
P2860
Q34438700-5C1CBE99-2EC9-4950-9B0F-42CCB98C3240Q34550961-74FB056C-28C9-4B4F-B2B0-9B6FA2E2D892Q35412202-4F9BAF2A-C59B-43A0-B49D-F68974EC0E56Q35829861-8D6FAA39-C221-4932-BB2E-9F0C3E6C1FD7Q35931441-A0FC862A-1B99-437C-9ED1-88DA10BFFD8CQ35972401-5129DC9D-CE2F-4F6E-8F1E-44753377491AQ36220792-5E1EA6F2-EEE3-4D38-B664-5FC8D97382A2Q36574546-F019D616-565B-4F05-98EE-DFFE616E0393Q37061792-58111815-CA68-4548-B2EE-1F21D8470231Q37536938-E575A3A9-F88F-4C98-998E-F4EB5FE5E393Q37578728-84EC0FB6-EEFE-4932-B1CD-9275F706905FQ37726126-C649F7FD-D419-4C43-B110-B4776CC189B6Q37977477-B5A946CD-4E4A-471A-A7D1-46E3EC7A436CQ37997086-78B5EAAB-A3C1-4101-93B4-47B2BAE91D5AQ38018997-C9AFFDC8-C0FA-4F1D-AC47-1679097BB13FQ38037620-EA41172A-1A17-4F3E-8A6F-BBD560190A52Q38074617-40CA0430-C0E7-4E66-BB21-B8EEC383642FQ38459836-DE7621A9-F1C9-4B38-B4DD-BA60693313BDQ38796064-70263E69-3D68-4870-91A8-EDB56790F0C9Q38826542-F65D8ECE-8365-4FCC-890D-DAEE1A108DA1Q38878493-95192C86-6857-40FE-AFBC-841440ED71B2Q38925268-1257F29F-3AEB-4C01-A24D-9AE599FF0268Q39068292-2A79A30D-9988-4871-BB33-744E3F3ED947Q39283792-17FBDB4A-1525-4FB3-B68B-67EECD7F6295Q45808302-BA58890A-3F63-4AA8-8626-464F2F320BC3Q46650908-2B49D73F-360C-4A67-A006-AD45448DBE2CQ48096452-523F204F-A131-4273-9EC4-3E509CF475FCQ49247817-0560B0E9-33D6-4D25-92C0-6D439EE3C0A4Q50252299-84BC9DD9-CBBE-4DEF-A77A-D3E3FE5F5A2FQ58789473-09F13910-128F-4122-8F2B-78778CDCAE33
P2860
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@en
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@nl
type
label
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@en
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@nl
prefLabel
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@en
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@nl
P2093
P1476
Epigenetics and chemoresistanc ...... novel therapeutic strategies.
@en
P2093
Cristina Napoli
Enrico Mini
Francesco Crea
Gabriele Perrone
Ida Landini
Romano Danesi
Stefania Nobili
P304
P356
10.1016/J.DRUP.2011.08.001
P577
2011-09-28T00:00:00Z